Quantitative proton MR spectroscopic imaging of the mesial temporal lobe

Journal of Magnetic Resonance Imaging

Volumn 20, Issue 5, 2004, Pages 772-778

  Arslanoglu, Atilla ^a   Bonekamp, David ^a   Barker, Peter B ^a,b   Horská, Alena ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

Author keywords

Choline; Hippocampus; Magnetic resonance spectroscopy; Mesial temporal lobe; N acetyl aspartate

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN REGION; EVALUATION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NEOCORTEX; NORMAL HUMAN; OLFACTORY CORTEX; PHANTOM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; TEMPORAL LOBE;

ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CHOLINE; CREATINE; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHANTOMS, IMAGING; REFERENCE VALUES; SIGNAL PROCESSING, COMPUTER-ASSISTED; TEMPORAL LOBE;

EID: 7044245793     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20195     Document Type: Article

References (32)

1. Wen HT, Rhoton Jr AL, de Oliveira E, et al. Microsurgical anatomy of the temporal lobe: part 1: mesial temporal lobe anatomy and its vascular relationships as applied to amygdalohippocampectomy. Neurosurgery 1999;45:549-591.
2. Insausti R, Insausti AM, Sobreviela MT, Salinas A, Martinez-Penuela JM. Human medial temporal lobe in aging: anatomical basis of memory preservation. Microsc Res Technol 1998;43:8-15.
3. Cendes F, Andermann F, Silver K, Arnold DL. Imaging of axonal damage in vivo in Rasmussen's syndrome. Brain 1995:118(Pt 3):753-758.
4. Vermathen P, Laxer KD, Matson GB, Weiner MW. Hippocampal structures: anteroposterior N-acetylaspartate differences in patients with epilepsy and control subjects as shown with proton MR spectroscopic imaging. Radiology 2000;214:403-410.
5. Nelson SJ. Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors. Magn Reson Med 2001;46:228-239.
6. Vigneron D, Bollen A, McDermott M, et al. Three-dimensional magnetic resonance spectroscopic imaging of histologically confirmed brain tumors. Magn Reson Imaging 2001;19:89-101.
7. Bernasconi A, Tasch E, Cendes F, Li LM, Arnold DL. Proton magnetic resonance spectroscopic imaging suggests progressive neuronal damage in human temporal lobe epilepsy. Prog Brain Res 2002; 135:297-304.
8. Guye M, Le Fur Y, Confort-Gouny S, et al. Metabolic and electrophysiological alterations in subtypes of temporal lobe epilepsy: a combined proton magnetic resonance spectroscopic imaging and depth electrodes study. Epilepsia 2002;43:1197-1209.
9. Simister RJ, Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS. A short-echo-time proton magnetic resonance spectroscopic imaging study of temporal lobe epilepsy. Epilepsia 2002;43: 1021-1031.
10. Weber-Fahr W, Ende G, Braus DF, et al. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage 2002;16:49-60.
11. Vermathen P, Laxer KD, Schuff N, Maison GB, Weiner MW. Evidence of neuronal injury outside the medial temporal lobe in temporal lobe epilepsy: N-acetylaspartate concentration reductions detected with multisection proton MR spectroscopic imaging-initial experience. Radiology 2003;226:195-202.
12. Choi CG, Frahm J. Localized proton MRS of the human hippocampus: metabolite concentrations and relaxation times. Magn Reson Med 1999;41:204-207.
13. Maton B, Londono A, Sawrie S, Knowlton R, denHollander J, Kuzniecky R. Reproducibility of proton magnetic resonance spectroscopy imaging measurements of normal human hippocampus at 1.5 T: clinical implications. J Neuroimaging 2001; 11:194-201.
14. McLean MA, Woermann FG, Simister RJ, Barker GJ, Duncan JS. In vivo short echo time 1H-magnetic resonance spectroscopic imaging (MRSI) of the temporal lobes. Neuroimage 2001;14:501-509.
15. Duyn JH, Gillen J, Sobering G, van Zijl PCM, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993;188:277-282.
16. Soher BJ, van Zijl PCM, Duyn JH, Barker PB. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996;35:356-363.
17. Horská A, Calhoun VD, Bradshaw DH, Barker PB. Rapid method for correction of CSF partial volume in quantitative prolon MR spectroscopic imaging. Magn Reson Med 2002;48:555-558.
18. Nolte J. The human brain: an introduction to its functional anatomy. St. Louis, Missouri: Mosby Yearbook: 1993. p 360-390.
19. Choi CG, Ko TS, Lee HK, Lee JH, Suh DC. Localized proton MR spectroscopy of the allocortex and isocortex in healthy children. AJNR Am J Neuroradiol 2000;21:1354-1358.
20. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993:13:981-989.
21. Barker PB, Szopinski K, Horská A. Metabolic heterogeneity at the level of the anterior and posterior commissures. Magn Reson Med 2000;43:348-354.
22. Mouritzen Dam A. The density of neurons in the human hippocampus. Neuropathol Appl Neurobiol 1979;5:249-264.
23. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298.
24. Capizzano AA, Vermathen P, Laxer KD, et al. Multisection proton MR spectroscopy for mesial temporal lobe epilepsy. AJNR Am J Neuroradiol 2002;23:1359-1368.
25. Wilson JL, Jenkinson M, Jezzard P. Optimization of static field homogeneity in human brain using diamagnetic passive shims. Magn Reson Med 2002;48:906-914.
26. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30: 424-437.
27. Brooks JC, Roberts N, Kemp GJ, Gosney MA, Lye M, Whitehouse GH. A proton magnetic resonance spectroscopy study of age-related changes in frontal lobe metabolite concentrations. Cereb Cortex 2001;11:598-605.
28. Christiansen P, Toft P, Larsson HB, Stubgaard M, Henriksen O. The concentration of N-acetyl aspartate, creatine + phosphocreatine and choline in different parts of the brain in adulthood and senium. Magn Reson Imaging 1993;11:799-806.
29. Huang W, Alexander GE, Daly EM, et al. High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am J Psychiatry 1999; 156:1879-1886.
30. Traber F, Block W, Lamerichs R, Gieseke J, Schild HH. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004;19:537-545.
31. W in ischaemic stroke patients: 1H MRS imaging and diffusion-weighted MRI. J Neurol Sci 2004; 220:23-28.
32. Brief EE, Whittall KP, Li DK, MacKay A. Proton T1 relaxation times of cerebral metabolites differ within and between regions of normal human brain. NMR Biomed 2003;16:503-509.